Iglesias, Juan F

Ikegami, Ryutaro; Piao, Zhonglie; Iglesias, Juan F; Pilgrim, Thomas; Ha, Khanh; McCarthy, Jason R; Castellanos, Maria I; Kassab, Mohamad B; Albagdadi, Mazen S; Mauskapf, Adam; Spicer, Graham; Kandzari, David E; Edelman, Elazer R; Libby, Peter; Heg, Dik; Joner, Michael; Tearney, Guillermo J; Jaffer, Farouc A (2024). Ultrathin-strut versus thin-strut stent healing and outcomes in preclinical and clinical subjects. EuroIntervention, 20(10), -e680. Europa Digital & Publishing 10.4244/EIJ-D-23-00563

Koliastasis, Leonidas; Bennett, Johan; Xaplanteris, Panagiotis; Skalidis, Ioannis; Guédès, Antoine; Demeure, Fabian; Vandeloo, Bert; Dugauquier, Christophe; Picard, Fabien; Warne, David W; Pilgrim, Thomas; Iglesias, Juan F; de Hemptinne, Quentin (2024). Two-year clinical outcomes of Resorbable Magnesium Scaffold versus conventional drug-eluting stents in ST-segment Elevation Myocardial Infarction: a propensity score matching analysis. Hellenic journal of cardiology, 78, pp. 84-86. Elsevier 10.1016/j.hjc.2023.12.004

Iglesias, Juan F; Roffi, Marco; Losdat, Sylvain; Muller, Olivier; Degrauwe, Sophie; Kurz, David J; Haegeli, Laurent; Weilenmann, Daniel; Kaiser, Christoph; Tapponnier, Maxime; Cook, Stéphane; Cuculi, Florim; Heg, Dik; Windecker, Stephan; Pilgrim, Thomas (2023). Long-term outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in ST-segment elevation myocardial infarction: 5-year follow-up of the BIOSTEMI randomised superiority trial. Lancet, 402(10416), pp. 1979-1990. Elsevier 10.1016/S0140-6736(23)02197-9

Georgiopoulos, Georgios; Kraler, Simon; Mueller-Hennessen, Matthias; Delialis, Dimitrios; Mavraganis, Georgios; Sopova, Kateryna; Wenzl, Florian A; Räber, Lorenz; Biener, Moritz; Stähli, Barbara E; Maneta, Eleni; Spray, Luke; Iglesias, Juan F; Coelho-Lima, Jose; Tual-Chalot, Simon; Muller, Olivier; Mach, François; Frey, Norbert; Duerschmied, Daniel; Langer, Harald F; ... (2023). Modification of the GRACE Risk Score for Risk Prediction in Patients With Acute Coronary Syndromes. JAMA cardiology, 8(10), pp. 946-956. American Medical Association 10.1001/jamacardio.2023.2741

Häner, Jonas D; Rohla, Miklos; Losdat, Sylvain; Iglesias, Juan F; Muller, Olivier; Eeckhout, Eric; Kurz, David; Weilenmann, Daniel; Kaiser, Christoph; Tapponnier, Maxime; Roffi, Marco; Heg, Dik; Windecker, Stephan; Pilgrim, Thomas (2023). Ultrathin-Strut versus Thin-Strut Drug-Eluting Stents for Multi- and Single-Stent Lesions: A Lesion-Level Subgroup Analysis of Two Randomized Trials. American Heart Journal, 263, pp. 73-84. Elsevier 10.1016/j.ahj.2023.05.004

Iglesias, Juan F; Muller, Olivier; Losdat, Sylvain; Roffi, Marco; Kurz, David J; Weilenmann, Daniel; Kaiser, Christoph; Heg, Dik; Windecker, Stephan; Pilgrim, Thomas (2023). Complex primary percutaneous coronary intervention with ultrathin-strut biodegradable versus thin-strut durable polymer drug-eluting stents in patients with ST-segment elevation myocardial infarction: A subgroup analysis from the BIOSTEMI randomized trial. Catheterization and cardiovascular interventions, 101(4), pp. 687-700. Wiley-Blackwell 10.1002/ccd.30600

de Hemptinne, Quentin; Xaplanteris, Panagiotis; Guédès, Antoine; Demeure, Fabian; Vandeloo, Bert; Dugauquier, Christophe; Picard, Fabien; Warne, David W; Pilgrim, Thomas; Iglesias, Juan F; Bennett, Johan (2022). Magmaris resorbable magnesium scaffold versus conventional drug-eluting stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison. Cardiovascular revascularization medicine, 43, pp. 28-35. Elsevier 10.1016/j.carrev.2022.05.028

Räber, Lorenz; Ueki, Yasushi; Otsuka, Tatsuhiko; Losdat, Sylvain; Häner, Jonas D; Lonborg, Jacob; Fahrni, Gregor; Iglesias, Juan F; van Geuns, Robert-Jan; Ondracek, Anna S; Radu Juul Jensen, Maria D; Zanchin, Christian; Stortecky, Stefan; Spirk, David; Siontis, George C; Saleh, Lanja; Matter, Christian M; Daemen, Joost; Mach, François; Heg, Dik; ... (2022). Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial. JAMA - the journal of the American Medical Association, 327(18), pp. 1771-1781. American Medical Association 10.1001/jama.2022.5218

Iglesias, Juan F; Heg, Dik; Roffi, Marco; Degrauwe, Sophie; Tüller, David; Muller, Olivier; Brinkert, Miriam; Cook, Stéphane; Weilenmann, Daniel; Kaiser, Christoph; Cuculi, Florim; Valgimigli, Marco; Jüni, Peter; Windecker, Stephan; Pilgrim, Thomas (2022). Five-year outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with acute coronary syndrome: A subgroup analysis of the BIOSCIENCE trial. Cardiovascular revascularization medicine, 34, pp. 3-10. Elsevier 10.1016/j.carrev.2021.02.008

Iglesias, Juan F; Degrauwe, Sophie; Cimci, Murat; Chatelain, Quentin; Roffi, Marco; Windecker, Stephan; Pilgrim, Thomas (2021). Differential Effects of Newer-Generation Ultrathin-Strut Versus Thicker-Strut Drug-Eluting Stents in Chronic and Acute Coronary Syndromes. JACC. Cardiovascular Interventions, 14(22), pp. 2461-2473. Elsevier 10.1016/j.jcin.2021.09.028

Iglesias, Juan F; Muller, Olivier; Losdat, Sylvain; Roffi, Marco; Kurz, David J; Weilenmann, Daniel; Kaiser, Christoph; Heg, Dik; Valgimigli, Marco; Windecker, Stephan; Pilgrim, Thomas (2021). Multivessel percutaneous coronary intervention with thin-strut biodegradable versus durable polymer drug-eluting stents in ST-segment-elevation myocardial infarction: A subgroup analysis of the BIOSTEMI randomized trial. International journal of cardiology, 334, pp. 37-41. Elsevier 10.1016/j.ijcard.2021.04.034

Pilgrim, Thomas; Rothenbühler, Martina; Siontis, George Cm; Kandzari, David E; Iglesias, Juan F; Asami, Masahiko; Lefèvre, Thierry; Piccolo, Raffaele; Koolen, Jacques; Saito, Shigeru; Slagboom, Ton; Muller, Olivier; Waksman, Ron; Windecker, Stephan (2021). Biodegradable polymer sirolimus-eluting stents vs durable polymer everolimus-eluting stents in patients undergoing percutaneous coronary intervention: A meta-analysis of individual patient data from 5 randomized trials. American Heart Journal, 235, pp. 140-148. Elsevier 10.1016/j.ahj.2021.02.009

Pilgrim, Thomas; Muller, Olivier; Heg, Dik; Roffi, Marco; Kurz, David J; Moarof, Igal; Weilenmann, Daniel; Kaiser, Christoph; Tapponnier, Maxime; Losdat, Sylvain; Eeckhout, Eric; Valgimigli, Marco; Jüni, Peter; Windecker, Stephan; Iglesias, Juan F (2021). Biodegradable- Versus Durable-Polymer Drug-Eluting Stents for STEMI: Final 2-Year Outcomes of the BIOSTEMI Trial. JACC. Cardiovascular Interventions, 14(6), pp. 639-648. Elsevier 10.1016/j.jcin.2020.12.011

Iglesias, Juan F; Muller, Olivier; Losdat, Sylvain; Roffi, Marco; Kurz, David J; Weilenmann, Daniel; Kaiser, Christoph; Valgimigli, Marco; Windecker, Stephan; Pilgrim, Thomas (2020). Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents for Primary PCI: A Subgroup Analysis of the BIOSTEMI Randomized Trial. JACC. Cardiovascular Interventions, 13(19), pp. 2314-2316. Elsevier 10.1016/j.jcin.2020.07.038

Koskinas, Konstantinos C; Windecker, Stephan; Pedrazzini, Giovanni; Mueller, Christian; Cook, Stéphane; Matter, Christian M; Muller, Olivier; Häner, Jonas; Gencer, Baris; Crljenica, Carmela; Amini, Poorya; Deckarm, Olga; Iglesias, Juan F; Räber, Lorenz; Heg, Dik; Mach, François (2019). Evolocumab for Early Reduction of LDL-Cholesterol Levels in Patients with Acute Coronary Syndromes (EVOPACS). Journal of the American College of Cardiology, 74(20), pp. 2452-2462. Elsevier 10.1016/j.jacc.2019.08.010

Iglesias, Juan F; Heg, Dik; Roffi, Marco; Tüller, David; Lanz, Jonas; Rigamonti, Fabio; Muller, Olivier; Moarof, Igal; Cook, Stéphane; Weilenmann, Daniel; Kaiser, Christoph; Cuculi, Florim; Valgimigli, Marco; Jüni, Peter; Windecker, Stephan; Pilgrim, Thomas (2019). Five-Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents. Journal of the American Heart Association, 8(22), e013607. American Heart Association 10.1161/JAHA.119.013607

Iglesias, Juan F; Muller, Olivier; Heg, Dik; Roffi, Marco; Kurz, David J; Moarof, Igal; Weilenmann, Daniel; Kaiser, Christoph; Tapponnier, Maxime; Stortecky, Stefan; Losdat, Sylvain; Eeckhout, Eric; Valgimigli, Marco; Odutayo, Ayodele; Zwahlen, Marcel; Jüni, Peter; Windecker, Stephan; Pilgrim, Thomas (2019). Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial. Lancet, 394(10205), pp. 1243-1253. Elsevier 10.1016/S0140-6736(19)31877-X

Iglesias, Juan F; Heg, Dierik Hans; Roffi, Marco; Tüller, David; Noble, Stéphane; Muller, Olivier; Moarof, Igal; Cook, Stéphane; Weilenmann, Daniel; Kaiser, Christoph; Cuculi, Florim; Häner, Jonas; Jüni, Peter; Windecker, Stephan; Pilgrim, Thomas (2019). Long-Term Effect of Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the BIOSCIENCE Randomized Trial. Circulation: Cardiovascular interventions, 12(8), e008024. Lippincott Williams & Wilkins 10.1161/CIRCINTERVENTIONS.119.008024

Iglesias, Juan F; Muller, Olivier; Heg, Dik; Roffi, Marco; Kurz, David J; Moarof, Igal; Weilenmann, Daniel; Kaiser, Christoph; Tapponnier, Maxime; Stortecky, Stefan; Losdat, Sylvain Pierre; Eeckhout, Eric; Valgimigli, Marco; Odutayo, Ayodele; Zwahlen, Marcel; Jüni, Peter; Windecker, Stephan; Pilgrim, Thomas (2019). Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial [Dataset].

Hugelshofer, Sarah; Roffi, Marco; Witassek, Fabienne; Eberli, Franz R; Pilgrim, Thomas; Pedrazzini, Giovanni; Rickli, Hans; Radovanovic, Dragana; Erne, Paul; Degrauwe, Sophie; Muller, Olivier; Masci, Pier Giorgio; Windecker, Stephan; Iglesias, Juan F (2018). Impact of total ischemic time on manual thrombus aspiration benefit during primary percutaneous coronary intervention. American Heart Journal, 204, pp. 34-42. Elsevier 10.1016/j.ahj.2018.05.019

Iglesias, Juan F; Muller, Olivier; Zaugg, Serge; Roffi, Marco; Kurz, David J; Vuilliomenet, André; Weilenmann, Daniel; Kaiser, Christoph; Tapponnier, Maxime; Heg, Dik; Valgimigli, Marco; Eeckhout, Eric; Jüni, Peter; Windecker, Stephan; Pilgrim, Thomas (2018). A comparison of an ultrathin strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for patients with acute stsegment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the BIOSTEMI trial. EuroIntervention, 14(6), pp. 692-699. Europa Digital & Publishing 10.4244/EIJ-D-17-00734

Fournier, Stephane; Muller, Olivier; Benedetto, Umberto; Roffi, Marco; Pilgrim, Thomas; Eberli, Franz R; Rickli, Hans; Radovanovic, Dragana; Erne, Paul; Cook, Stéphane; Noble, Stéphane; Fesselet, Rachel; Zuffi, Andrea; Degrauwe, Sophie; Masci, PierGiorgio; Windecker, Stephan; Eeckhout, Eric; Iglesias, Juan F (2018). Circadian dependence of manual thrombus aspiration benefit in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Clinical research in cardiology, 107(4), pp. 338-346. Springer-Medizin-Verlag 10.1007/s00392-017-1189-8

Iglesias, Juan F; Roffi, Marco; Degrauwe, Sophie; Secco, Gioel Gabrio; Aminian, Adel; Windecker, Stephan; Pilgrim, Thomas (2017). Orsiro cobalt-chromium sirolimus-eluting stent: present and future perspectives. Expert review of medical devices, 14(10), pp. 773-788. Taylor & Francis 10.1080/17434440.2017.1378091

Piccolo, Raffaele; Heg, Dik; Franzone, Anna; Roffi, Marco; Tüller, David; Vuilliomenet, André; Muller, Olivier; Cook, Stéphane; Weilenmann, Daniel; Kaiser, Christoph; Jamshidi, Peiman; Iglesias, Juan F; Windecker, Stephan; Pilgrim, Thomas (2016). Biodegradable-Polymer Sirolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in Patients With Acute ST-Segment Elevation Myocardial Infarction: Insights From the 2-Year Follow-Up of the BIOSCIENCE Trial. JACC. Cardiovascular Interventions, 9(9), pp. 981-983. Elsevier 10.1016/j.jcin.2016.02.044

Schoenenberger, Andreas; Radovanovic, Dragana; Windecker, Stephan; Iglesias, Juan F; Pedrazzini, Giovanni; Stuck, Andreas; Erne, Paul (2016). Temporal trends in the treatment and outcomes of elderly patients with acute coronary syndrome. European Heart Journal, 37(16), pp. 1304-1311. Oxford University Press 10.1093/eurheartj/ehv698